Table 1.
Baseline Clinical Characteristics (n=227)
| Age (years) | 59.2±10.8 |
| Male | 164 (72.2) |
| BMI (kg/m2) | 24.6±3.3 |
| PAF (vs. non-PAF) | 160 (70.5) |
| Structural heart disease | 35 (15.4) |
| Hypertension | 90 (39.6) |
| Diabetes mellitus | 26 (11.5) |
| CHADS2 score | 0.82±0.93 |
| CHA2DS2-VASc score | 1.49±1.30 |
| Anatomical data | |
| Longitudinal diameter of the PV ostium (mm) | 18.1±3.3 |
| Left superior PV (mm) | 19.6±3.3 |
| Left inferior PV (mm) | 16.3±2.4 |
| Right superior PV (mm) | 19.1±3.0 |
| Right inferior PV (mm) | 17.2±3.2 |
| LAD (mm) | 39.0±7.1 |
| LAVI (mL/m2) | 39.2±13.7 |
| LVEF (%) | 61.5±9.5 |
| Laboratory data | |
| eGFR (mL/min/1.73 m2) | 72.2±17.9 |
| BNP (pg/mL) | 124.3±198.9 |
| Procedural data | |
| CF-sensing catheter in 1 st session | 88 (38.8) |
| CF-sensing catheter in 2nd session | 28/49 (57.1) |
Data given as n (%) or mean±SD. BMI, body mass index; BNP, brain natriuretic peptide; CF, contact force; eGFR, estimated glomerular filtration rate; LAD, left atrial diameter; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; PAF, paroxysmal atrial fibrillation; PV, pulmonary vein.